Hidekazu Segawa

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 244 citations · Full text

Medicine, Oncology, Pharmacology +7

Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer

Masaki Nogawa, Takeshi Yuasa, Shinya Kimura et al. · Journal of Clinical Investigation · 2005 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

Cytotoxic effects of γδ T cells expanded <i>ex vivo</i> by a third generation bisphosphonate for cancer immunotherapy

Kiyoshi Sato, Shinya Kimura, Hidekazu Segawa et al. · International Journal of Cancer · 2005 · 142 citations

Medicine, Oncology, Pharmacology +17

Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines

Seiji Matsumoto, Shinya Kimura, Hidekazu Segawa et al. · Lung Cancer · 2004 · 125 citations

Medicine, Oncology, Pharmacology +9

Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models

Masaki Nogawa, Takeshi Yuasa, Shinya Kimura et al. · Cancer Letters · 2004 · 85 citations

Medicine, Cancer Biology, Oncology +14